Ruhrchemie

25.09.2013 • News

Oxea Celebrates 75 Years of Oxo Synthesis

On September 20, 1938, the German chemist, Dr. Otto Roelen, then the research director at Ruhrchemie in Oberhausen (now Oxea), filed a patent application for the oxo synthesis.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.